Next Treatments
Back to Eczema

VC005

TypeTopical StagePhase 3 Latest updateJun 1, 2026Phase 2 study started

History

Earliest recorded event: Jul 27, 2023. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

  • Jun 1, 2026Phase 2 trial startedA Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT07598383
  • May 12, 2026Phase 3 trial startedPhase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT07592585
  • Feb 28, 2026Phase 1 trial completedClinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT07329101
  • Feb 6, 2026Phase 1 main data collectedClinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT07329101
  • Nov 11, 2025Phase 1 trial startedClinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT07329101
  • Nov 4, 2025Phase 2 trial completedPhase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT06891040
  • Oct 31, 2025Phase 2 main data collectedPhase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT06891040
  • Apr 28, 2025Phase 2 trial startedPhase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT06891040
  • May 23, 2024Phase 1 trial completedSafety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT06009094
  • Jul 27, 2023Phase 1 trial startedSafety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis ClinicalTrials.gov NCT06009094

Sources

Trials